Value Line - The Most Trusted Name in Investment Research - Stock Quotes

Quote Lookup

Please enter a ticker symbol below and click Submit.
Symbol:        VL Survey Page (2015-01-09)Premium Content

Biogen Idec Inc (BIIB)

2015-03-03@06:18:08 ET
Mature Biotech Outlook 2015: New Therapy Ventures Pave the Way for Success, New Report Launched (MTO)

2015-03-02@18:12:28 ET
Biogen Idec, Sobi report positive top-line results from Phase III Kids B-LONG trial of Alprolix (ABW)

2015-03-02@16:49:55 ET
After Yesterday's Rally of 1.51% Shares Could Potentially Pullback (PSM)

2015-03-02@16:49:25 ET
After Yesterday's Rally of 1.51% Shares Could Potentially Pullback (PSM)

2015-03-02@15:30:13 ET
Biogen Idec: The Winning Streak Continues (BIIB) (F71)

2015-03-02@13:30:21 ET
Biogen Idec (BIIB) Breaks Through Resistance at $412.00 (F79)

2015-03-02@11:07:15 ET
Brain Injury Therapeutics Pipeline Review 2015 - 5 Companies & 10 Drug Profiles (MTO)

2015-03-02@09:22:00 ET
Secondary Progressive Multiple Sclerosis (SPMS) Therapeutics Pipeline Review 2015 - 11 Companies & 15 Drug Profiles (MTO)

2015-03-02@08:29:55 ET
Biogen Idec (BIIB) Showing Bullish Technicals With Support At $403.39 (FBM)

2015-03-02@08:00:02 ET
Novo Nordisk, Takeda, Servier, Celgene Among Top Sponsors Rated by Investigative Sites in New CenterWatch Survey (BIZ)

2015-02-27@14:19:35 ET
Biogen Idec (BIIB) Showing Bullish Technicals With Support At $403.61 (FBM)

2015-02-27@07:06:26 ET
Biogen Idec and Sobi announce positive top-line efficacy and safety results from phase 3 Alprolix(R) paediatric study (HUG)

2015-02-27@07:00:01 ET
Biogen Idec and Sobi Announce Positive Top-Line Efficacy and Safety Results from Phase 3 ALPROLIX(R) Pediatric Study (BIZ)

2015-02-26@16:48:00 ET
AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting (PRN)

2015-02-26@12:33:00 ET
BIOGEN IDEC REPORTS ACQUISITION BY EXECUTIVE VP AND GLOBAL COMM. OPERATIONS KINGSLEY (Massachusetts) (ABW)

2015-02-26@11:41:16 ET
Form 144: Filing to Sell 2128 Shares of Biogen Idec Inc (BIIB) (VKR)

2015-02-26@11:41:06 ET
Form 144: Filing to Sell 486 Shares of Biogen Idec Inc (BIIB) (VKR)